Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024

Stock Price vs Company Growth
1d
0.8%
1w
2.0%
1m
5.8%
3m
26.1%
6m
61.5%
1y
77.4%
all
49.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,567 0.8%
1,189
1,687
Company Overview

Sales
2,250 Cr
Growth: 18.0%
Profit after Tax
361 Cr
Growth: 3.7%
Large Cap
33,286 Cr
P/E: 92.4x
Industry P/E: 35.4x
Fundamentals

Sales (Cr) ₹ 2,250
Growth 18.0%
EBITDA 29.3%
P/S 14.8x
Dividend 0.0%
P/E 92.4x
Book Value ₹ 120
PEG Ratio 5.2x
ROE 14.9%
P/B 13.1x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms. Awards, accreditations and recognitions2020: Awarded the ‘Risk Mitigation Award’ by Institute of Supply Chain Management Pvt. Ltd.
Followers (1)